Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 4
1966 4
1967 6
1968 11
1969 5
1970 14
1971 9
1972 16
1973 13
1974 14
1975 10
1976 7
1977 11
1978 15
1979 11
1980 5
1981 13
1982 20
1983 6
1984 23
1985 19
1986 15
1987 26
1988 31
1989 24
1990 19
1991 16
1992 24
1993 10
1994 13
1995 18
1996 17
1997 19
1998 22
1999 17
2000 31
2001 21
2002 31
2003 32
2004 28
2005 25
2006 40
2007 43
2008 41
2009 36
2010 57
2011 48
2012 67
2013 64
2014 47
2015 52
2016 50
2017 65
2018 48
2019 50
2020 63
2021 70
2022 69
2023 63
2024 39

Search Results

1,550 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
Gross AM, Dombi E, Wolters PL, Baldwin A, Dufek A, Herrera K, Martin S, Derdak J, Heisey KS, Whitcomb PM, Steinberg SM, Venzon DJ, Fisher MJ, Kim A, Bornhorst M, Weiss BD, Blakeley JO, Smith MA, Widemann BC. Gross AM, et al. Neuro Oncol. 2023 Oct 3;25(10):1883-1894. doi: 10.1093/neuonc/noad086. Neuro Oncol. 2023. PMID: 37115514 Free PMC article. Clinical Trial.
Ophthalmic manifestations in neurofibromatosis type 1.
Kinori M, Hodgson N, Zeid JL. Kinori M, et al. Surv Ophthalmol. 2018 Jul-Aug;63(4):518-533. doi: 10.1016/j.survophthal.2017.10.007. Epub 2017 Nov 16. Surv Ophthalmol. 2018. PMID: 29080631 Review.
Drug therapy for neurofibromatosis?
Meyer LJ. Meyer LJ. Arch Dermatol. 1993 May;129(5):625-6. Arch Dermatol. 1993. PMID: 8481024 No abstract available.
Neurofibromatosis 1: from lab bench to clinic.
Ward BA, Gutmann DH. Ward BA, et al. Pediatr Neurol. 2005 Apr;32(4):221-8. doi: 10.1016/j.pediatrneurol.2004.11.002. Pediatr Neurol. 2005. PMID: 15797177 Review.
1,550 results